The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Yan BeauverdSarah MorinCaroline StephanCarmen De Ramon OrtizMarta Fabra UrdiolaFederica GiannottiElif MahneAnne-Claire MamezMaria MappouraFederico SimonettaThien-An TranChristian AyerSarah NoetzlinIsaline VerdonStavroula Masouridi-LevratYves ChalandonPublished in: Bone marrow transplantation (2021)